327 related articles for article (PubMed ID: 24025927)
1. Response criteria in oncologic imaging: review of traditional and new criteria.
Tirkes T; Hollar MA; Tann M; Kohli MD; Akisik F; Sandrasegaran K
Radiographics; 2013; 33(5):1323-41. PubMed ID: 24025927
[TBL] [Abstract][Full Text] [Related]
2. Radiologic assessment of response to therapy: comparison of RECIST Versions 1.1 and 1.0.
Chalian H; Töre HG; Horowitz JM; Salem R; Miller FH; Yaghmai V
Radiographics; 2011; 31(7):2093-105. PubMed ID: 22084190
[TBL] [Abstract][Full Text] [Related]
3. Revised RECIST guideline version 1.1: What oncologists want to know and what radiologists need to know.
Nishino M; Jagannathan JP; Ramaiya NH; Van den Abbeele AD
AJR Am J Roentgenol; 2010 Aug; 195(2):281-9. PubMed ID: 20651182
[TBL] [Abstract][Full Text] [Related]
4. Tumor response evaluation in oncology: current update.
Shanbhogue AK; Karnad AB; Prasad SR
J Comput Assist Tomogr; 2010 Jul; 34(4):479-84. PubMed ID: 20657213
[TBL] [Abstract][Full Text] [Related]
5. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
Lencioni R; Llovet JM
Semin Liver Dis; 2010 Feb; 30(1):52-60. PubMed ID: 20175033
[TBL] [Abstract][Full Text] [Related]
6. The role of response evaluation criteria in solid tumour in anticancer treatment evaluation: results of a survey in the oncology community.
Liu Y; Litière S; de Vries EG; Sargent D; Shankar L; Bogaerts J; Seymour L
Eur J Cancer; 2014 Jan; 50(2):260-6. PubMed ID: 24239447
[TBL] [Abstract][Full Text] [Related]
7. From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.
Wahl RL; Jacene H; Kasamon Y; Lodge MA
J Nucl Med; 2009 May; 50 Suppl 1(Suppl 1):122S-50S. PubMed ID: 19403881
[TBL] [Abstract][Full Text] [Related]
8. [Measurement of tumour response to cancer treatment: morphologic imaging role].
Ollivier L; Leclère J; Thiesse P; Di Stefano D; Vincent C
Bull Cancer; 2007 Feb; 94(2):171-7. PubMed ID: 17337386
[TBL] [Abstract][Full Text] [Related]
9. Radiologic measurements of tumor response to treatment: practical approaches and limitations.
Suzuki C; Jacobsson H; Hatschek T; Torkzad MR; Bodén K; Eriksson-Alm Y; Berg E; Fujii H; Kubo A; Blomqvist L
Radiographics; 2008; 28(2):329-44. PubMed ID: 18349443
[TBL] [Abstract][Full Text] [Related]
10. RECIST revisited: a review of validation studies on tumour assessment.
Therasse P; Eisenhauer EA; Verweij J
Eur J Cancer; 2006 May; 42(8):1031-9. PubMed ID: 16616487
[TBL] [Abstract][Full Text] [Related]
11. Quantitative imaging in oncology patients: Part 2, oncologists' opinions and expectations at major U.S. cancer centers.
Jaffe TA; Wickersham NW; Sullivan DC
AJR Am J Roentgenol; 2010 Jul; 195(1):W19-30. PubMed ID: 20566776
[TBL] [Abstract][Full Text] [Related]
12. Selection of response criteria for clinical trials of sarcoma treatment.
Schuetze SM; Baker LH; Benjamin RS; Canetta R
Oncologist; 2008; 13 Suppl 2():32-40. PubMed ID: 18434637
[TBL] [Abstract][Full Text] [Related]
13. Assessment of liver tumor response to therapy: role of quantitative imaging.
Gonzalez-Guindalini FD; Botelho MP; Harmath CB; Sandrasegaran K; Miller FH; Salem R; Yaghmai V
Radiographics; 2013 Oct; 33(6):1781-800. PubMed ID: 24108562
[TBL] [Abstract][Full Text] [Related]
14. Response evaluation criteria in solid tumors (RECIST): new guidelines.
Tsuchida Y; Therasse P
Med Pediatr Oncol; 2001 Jul; 37(1):1-3. PubMed ID: 11466715
[No Abstract] [Full Text] [Related]
15. Imaging response assessment in oncology.
Curran SD; Muellner AU; Schwartz LH
Cancer Imaging; 2006 Oct; 6(Spec No A):S126-30. PubMed ID: 17114065
[TBL] [Abstract][Full Text] [Related]
16. [A summary report of response evaluation criteria in solid tumors (RECIST criteria)].
Kusaba H; Saijo N
Gan To Kagaku Ryoho; 2000 Jan; 27(1):1-5. PubMed ID: 10660728
[TBL] [Abstract][Full Text] [Related]
17. High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria.
Stacchiotti S; Collini P; Messina A; Morosi C; Barisella M; Bertulli R; Piovesan C; Dileo P; Torri V; Gronchi A; Casali PG
Radiology; 2009 May; 251(2):447-56. PubMed ID: 19261927
[TBL] [Abstract][Full Text] [Related]
18. Imaging assessment of tumor response: past, present and future.
Afaq A; Akin O
Future Oncol; 2011 May; 7(5):669-77. PubMed ID: 21568682
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?
Forner A; Ayuso C; Varela M; Rimola J; Hessheimer AJ; de Lope CR; Reig M; Bianchi L; Llovet JM; Bruix J
Cancer; 2009 Feb; 115(3):616-23. PubMed ID: 19117042
[TBL] [Abstract][Full Text] [Related]
20. A statistical simulation study finds discordance between WHO criteria and RECIST guideline.
Mazumdar M; Smith A; Schwartz LH
J Clin Epidemiol; 2004 Apr; 57(4):358-65. PubMed ID: 15135836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]